首页> 美国卫生研究院文献>Reproductive Sciences >Immunohistochemical Detection of Promyelocytic Leukemia Zinc Finger and Histone 1.5 in Uterine Leiomyosarcoma and Leiomyoma
【2h】

Immunohistochemical Detection of Promyelocytic Leukemia Zinc Finger and Histone 1.5 in Uterine Leiomyosarcoma and Leiomyoma

机译:免疫组织化学检测子宫平滑肌肉瘤和平滑肌瘤中早幼粒细胞白血病锌指和组蛋白1.5

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objectives:The accurate distinction of leiomyoma from leiomyosarcoma is essential for patient management. However, the distinction can be difficult to make, particularly in tissue biopsy samples. Immunohistochemistry has been established as a useful technique to aid in the diagnosis of malignancies. The advantages of immunohistochemical studies are their ease of use and interpretation. This study is the first to evaluate the utility of the promyelocytic leukemia zinc finger (PLZF) protein and the histone 1.5 (H1.5) protein as potential diagnostic immunohistochemical markers for distinguishing leiomyosarcoma from leiomyoma.
机译:目的:准确区分平滑肌肉瘤和平滑肌肉瘤对患者的治疗至关重要。但是,很难区分,特别是在组织活检样本中。免疫组织化学已被确立为有助于诊断恶性肿瘤的有用技术。免疫组化研究的优点是易于使用和解释。这项研究是第一个评估早幼粒细胞白血病锌指(PLZF)蛋白和组蛋白1.5(H1.5)蛋白作为区分平滑肌肉瘤和平滑肌肉瘤的潜在诊断免疫组化标志物的实用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号